Basic and Clinical Neuroscience (Sep 2022)

Transdifferentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Dopaminergic Neurons in a Three-Dimensional Culture

  • Ardeshir Moayeri,
  • Rafieh Alizadeh,
  • Hatef Ghasemi Hamidabadi,
  • Maryam Nazm Bojnordi,
  • Ali Niapour,
  • Azim Hedayatpour,
  • Marzieh Darvishi,
  • Fatemeh Heidari,
  • Maryam Soleimani,
  • Leila Elyasi

Journal volume & issue
Vol. 13, no. 5
pp. 625 – 636

Abstract

Read online

Introduction: The induction of human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) toward dopaminergic neurons is a major challenge in tissue engineering and experimental and clinical treatments of various neurodegenerative diseases, including Parkinson disease. This study aims to differentiate HUC-MSCs into dopaminergic neuron-like cells. Methods: Following the isolation and characterization of HUC-MSCs, they were transferred to Matrigel-coated plates and incubated with a cocktail of dopaminergic neuronal differentiation factors. The capacity of differentiation into dopaminergic neuron-like cells in 2-dimensional culture and on Matrigel was assessed by real-time polymerase chain reaction, immunocytochemistry, and high-performance liquid chromatography. Results: Our results showed that dopaminergic neuronal markers’ transcript and protein levels were significantly increased on the Matrigel differentiated cells compared to 2D culture plates. Conclusion: Overall, the results of this study suggest that HUC-MSCs can successfully differentiate toward dopaminergic neuron-like cells on Matrigel, having great potential for the treatment of dopaminergic neuron-related diseases.

Keywords